NAPSA Primary Antibody

Item Information
Catalog #Size/ConcentrationPrice
Specification
AliasesKAP; Kdap; NAP1; NAPA; SNAPA
ProductOrderN
Clone#10C4B8
Entrez GenelD9476
FormulationPurified antibody in PBS with 0.05% sodium azide
HostMouse
IsotypeIgG1
ImmunogenPurified recombinant fragment of human NAPSA (AA: 20-158) expressed in E. Coli.
MW45.4kDa
Shipping InformationThis product will ship in a box containing blue ice at a temperature of 4°C. Learn More
Species ReactivityHuman, Rat
Application
ELISA1/10000
IHC_P(Immunohistochemistry)1/200 - 1/1000
WB (Western Blot)1/500 - 1/2000
Sequence
20-158
Catalog#: 30515
Inquire
Contact us to order
Images
Western Blot
Figure 1: Western blot analysis using NAPSA mAb against human NAPSA recombinant protein. (Expected MW is 40.9 kDa)
Figure 1: Western blot analysis using NAPSA mAb against human NAPSA recombinant protein. (Expected MW is 40.9 kDa)
Western Blot
Figure 2: Western blot analysis using NAPSA mAb against HEK293 (1) and NAPSA (AA: 20-158)-hIgGFc transfected HEK293 (2) cell lysate.
Figure 2: Western blot analysis using NAPSA mAb against HEK293 (1) and NAPSA (AA: 20-158)-hIgGFc transfected HEK293 (2) cell lysate.
Western Blot
Figure 3: Western blot analysis using NAPSA mouse mAb against rat liver tissue lysate.
Figure 3: Western blot analysis using NAPSA mouse mAb against rat liver tissue lysate.
Immunohistochemical analysis
Figure 4: Immunohistochemical analysis of paraffin-embedded rectum cancer tissues using NAPSA mouse mAb with DAB staining.
Figure 4: Immunohistochemical analysis of paraffin-embedded rectum cancer tissues using NAPSA mouse mAb with DAB staining.
Immunohistochemical analysis
Figure 5: Immunohistochemical analysis of paraffin-embedded liver cancer tissues using NAPSA mouse mAb with DAB staining.
Figure 5: Immunohistochemical analysis of paraffin-embedded liver cancer tissues using NAPSA mouse mAb with DAB staining.
Elisa
Black line: Control Antigen (100 ng); Purple line: Antigen(10ng); Blue line: Antigen (50 ng); Red line: Antigen (100 ng);
Black line: Control Antigen (100 ng); Purple line: Antigen(10ng); Blue line: Antigen (50 ng); Red line: Antigen (100 ng);
Product Overview
DescriptionThe activation peptides of aspartic proteinases plays role as inhibitors of the active site. These peptide segments, or pro-parts, are deemed important for correct folding, targeting, and control of the activation of aspartic proteinase zymogens. The pronapsin A gene is expressed predominantly in lung and kidney. Its translation product is predicted to be a fully functional, glycosylated aspartic proteinase precursor containing an RGD motif and an additional 18 residues at its C-terminus.


References (references)
References (references)1. Lung Cancer. 2012 Jul;77(1):156-61.
2. Cancer Cytopathol. 2011 Oct 25;119(5):335-45.